| Variables | Non-OSA n = 91 | Mild n = 76 | Moderate n = 57 | Severe n = 76 | P-value | |
| Age (years) | 41.7 ± 14.0 | 51.2 ± 11.7 | 53.4 ± 12.5 | 55.7 ± 11.2 | <0.001* | |
| BMI (kg/m2) | 33.9 ± 7.6 | 35.1 ± 7.0 | 38.5 ± 8.8 | 41.2 ± 6.9 | <0.001* | |
| HTN | 24 (26.4) | 22 (28.9) | 23 (40.4) | 57 (75.0) | 0.013* | |
| Severity of HTN1 (n = 126) | Monotherapy | 12 (50.0) | 8 (36.4) | 6 (26.1) | 8 (14.0) | 0.037* |
| 2-line therapy | 7 (29.2) | 8 (36.4) | 9 (39.1) | 22 (38.6) | ||
| ≥3-line therapy | 5 (20.8) | 6 (27.3) | 8 (34.8) | 27 (47.4) | ||
| T2DM | 20 (22.0) | 24 (31.6) | 20 (35.1) | 34 (44.7) | 0.040* | |
| Severity of T2DM2 (n = 98) | Monotherapy | 11 (55.0) | 11 (45.8) | 5 (25.0) | 4 (11.8) | 0.017* |
| 2-line therapy | 5 (25.0) | 7 (29.2) | 6 (30.0) | 11 (32.4) | ||
| ≥3-line therapy | 4 (20.0) | 6 (25.0) | 9 (45.0) | 19 (55.9) | ||
| Sleep efficiency | 79.0 ± 14.7 | 75.1 ± 16.5 | 71.8 ± 15.8 | 69.6 ± 17.6 | 0.022* | |
| AHI (event/H) | 3.6 ± 3.3 | 12.5 ± 8.0 | 22.0 ± 4.5 | 54.0 ± 20.1 | <0.001* | |
| STOP-BANG score | 3.9 ± 1.6 | 6.2 ± 0.8 | 6.4 ± 0.8 | 6.8 ± 0.8 | <0.001* | |
| Nadir O2 sat% | 91.7 ± 2.5 | 87.0 ± 4.3 | 82.5 ± 7.7 | 74.9 ± 14.2 | <0.001* | |
| HBA1C2 for patients with T2DM | 7.1 ± 1.6 | 8.1 ± 1.5 | 8.5 ± 1.5 | 8.7 ± 1.2 | 0.004* | |